Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Autor: | Pascale Lejeune, Francesca Zanconato, Andrea Manfrin, Erika Quaranta, Daniele Di Biagio, Vincenza Guzzardo, Letizia Filippi, Bernard Haendler, Luca Azzolin, Jeroen Krijgsveld, Mattia Forcato, Giusy Battilana, Michelangelo Cordenonsi, Gianluca Sigismondo, Silvio Bicciato, Stefano Piccolo, Matteo Fassan |
---|---|
Rok vydání: | 2018 |
Předmět: |
Genetics and Molecular Biology (all)
0301 basic medicine BRD4 Biochemistry Genetics and Molecular Biology (all) HEK 293 cells Promoter General Medicine Biology Phosphoproteins Biochemistry Article General Biochemistry Genetics and Molecular Biology Chromatin Cell biology 03 medical and health sciences 030104 developmental biology Coactivator Cancer cell Humans Enhancer Transcription factor Adaptor Proteins Signal Transducing |
Zdroj: | Nature medicine Nature Medicine |
ISSN: | 1546-170X 1078-8956 |
Popis: | Cancer cells rely on dysregulated gene expression. This establishes specific transcriptional addictions that may be therapeutically exploited. Yet, the mechanisms that are ultimately responsible for these addictions are poorly understood. Here, we investigated the transcriptional dependencies of transformed cells to the transcription factors YAP and TAZ. YAP/TAZ physically engage the general coactivator bromodomain-containing protein 4 (BRD4), dictating the genome-wide association of BRD4 to chromatin. YAP/TAZ flag a large set of enhancers with super-enhancer-like functional properties. YAP/TAZ-bound enhancers mediate the recruitment of BRD4 and RNA polymerase II at YAP/TAZ-regulated promoters, boosting the expression of a host of growth-regulating genes. Treatment with small-molecule inhibitors of BRD4 blunts YAP/TAZ pro-tumorigenic activity in several cell or tissue contexts, causes the regression of pre-established, YAP/TAZ-addicted neoplastic lesions and reverts drug resistance. This work sheds light on essential mediators, mechanisms and genome-wide regulatory elements that are responsible for transcriptional addiction in cancer and lays the groundwork for a rational use of BET inhibitors according to YAP/TAZ biology. |
Databáze: | OpenAIRE |
Externí odkaz: |